• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

HCV Call for 10/13/15 - Layoffs?

Quote




































































Doesn't matter what market share we hit. A big shout out to all the outside, nonvested idiots who quit HCV!!

Thanks to all of these idiots, us remaining HCV reps are good for probably at least another year of guaranteed employment regardless of our market share. What a stroke of luck that is! A year or more of job security in Pharma is an eternity!
Without these asswipes quitting, they would of had to lay off many of us.
CCCCC-Ching!!!!!!!!!!!
 




anonymous said:
Doesn't matter what market share we hit. A big shout out to all the outside, nonvested idiots who quit HCV!!

Thanks to all of these idiots, us remaining HCV reps are good for probably at least another year of guaranteed employment regardless of our market share. What a stroke of luck that is! A year or more of job security in Pharma is an eternity!
Without these asswipes quitting, they would of had to lay off many of us.
CCCCC-Ching!!!!!!!!!!!
Click to expand...

What an idiot! A year. Wow. Who manages their career like that.
 








Top Bottom
Back
Quote